NUAKs are AMPK-related kinases (ARKs). There are two known family members, NUAK1 (ARK5) and NUAK2 (SNARK), which are activated by liver kinase B1 (LKB1) and are important in cancer progression and metastasis, as well as carbohydrate metabolism.

Literature (1)
Pathways (2)
Gene Data

NUAK Inhibitors

Cat. No. Product Name / Activity
5622 HTH 01-015
Potent and selective NUAK1 inhibitor
5177 WZ 4003
Potent and selective NUAK1/2 inhibitor

NUAKs are AMPK-related kinases (ARK) and members of the calcium/calmodulin-dependent protein kinase-like (CAMKL) family of enzymes. Two NUAKs have been described, NUAK1 (ARK5) and NUAK2 (SNARK), both of which are 76kDa proteins containing an ubiquitin-associated domain located next to the C-terminal of the catalytic domain, which is required for liver kinase B1 (LKB1, also known as serine/threonine kinase 11) phosphorylation and activation. Myosin phosphatase complex subunit (MYPT1) is a substrate of both.

NUAK1 is expressed in heart, kidney, brain, liver and skeletal muscle, and is localized in the cytoplasm. Expression is associated with matrix metalloproteinases 2 and 9, and with the S100 calcium binding protein A4 (S100A4) and BRAF. NUAK1 promotes cancer cell survival and suppresses cell death during glucose starvation. It also has a role in facilitating cell motility and is a major factor in cancer cell migration and invasion. In addition, in tumor cells overexpressing MYC, NUAK1 is required for maintaining cell viability. It has been postulated that Akt mediates its effects on tumor cell survival and migration via NUAK1. Inhibition of NUAK1 has been shown to suppress tumor formation and prolong survival in a mouse model, suggesting the enzyme has potential as a target for cancer chemotherapy.

NUAK2 is expressed in kidney, thymus, spleen, stomach, and at high levels in skin, testis, uterus, ovary, adrenals and brain, and is primarily localized in the cell nucleus. NUAK2 expression is increased in the skeletal muscle of obese human subjects as well as in various cancers. Snark+/- knockout mice develop mature onset obesity and symptoms associated with type 2 diabetes mellitus in humans. Glucose deprivation increases both NUAK 1 and 2 activity. NUAK2 is also activated in response to other stresses, including hyperosmotic stress, DNA damage, oxidative stress and AMP, and like NUAK1, has a role in cancer cell motility and survival.

External sources of pharmacological information for NUAKs :

Literature for NUAKs

Tocris offers the following scientific literature for NUAKs to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Programmed Cell Death Poster

Programmed Cell Death Poster

There are two currently recognized forms of programmed cell death: apoptosis and necroptosis. This poster summarizes the signaling pathways involved in apoptosis, necroptosis and cell survival following death receptor activation, and highlights the influence of the molecular switch, cFLIP, on cell fate.

Pathways for NUAKs

AMPK Signaling Pathway

AMPK Signaling Pathway

AMPK signaling pathway plays an important role in the cellular reponse to low levels of available ATP, often caused by stresses such as heat shock, ischemia or hypoxia.
Akt Signaling Pathway

Akt Signaling Pathway

The Akt signaling pathway plays a key role in the mediation of protein synthesis, metabolism, proliferation and cell cycle progression. It may be referred to as a 'prosurvival' pathway.

NUAK Gene Data

Gene Species Gene Symbol Gene Accession No. Protein Accession No.
NUAK1 Human NUAK1 NM_014840 O60285
Mouse Nuak1 NM_001004363 Q641K5
Rat Nuak1 NM_001106774 NP_001100244
NUAK2 Human NUAK2 NM_030952 Q9H093
Mouse Nuak2 NM_001195025 Q8BZN4
Rat Nuak2 NM_001007617 Q66HE5